FDA Announces Approval of Guidance for Automated Blood Cell Separator Devices

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to guidance for industry and FDA staff on Class II special controls for automated blood cell separator devices operating by centrifugal or filtration separation principle. This guidance is now effective.